Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
XERS
$8.60
+3.24%
XERS · Xeris Biopharma Holdings, Inc.
$8.60
+0.27 (+3.24%)
At close · Aug 14
Market Cap
$1.57B
Shares
182.32M
All earnings calls
Earnings call · FY2026 Q2
Xeris Biopharma Holdings, Inc. Q2 FY2026 Earnings Call
Xeris Biopharma Holdings, Inc. Q2 FY2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$92.10M
+28.7% YoY
Diluted EPS
-$0.18
Net income
-$31.10M
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 6, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Total revenue
full-year 2026
|
$385M – $390M | — |
SEC filing · Item 2.02
8-K earnings release
Filed Aug 6, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 6, 2026 · complete as-filed document